This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Papademetriou, V. Articles by Lakshman, R. Search for Related Content PubMed Articles by Papademetriou, V. Articles by Lakshman, R. Social Bookmarking                         What's this?

Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA, papavip@ aol.com

Philippe Mammillot

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA

Robert Redman

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA

Aldo Notargiacomo

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA

Puneet Narayan

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA

Raj Lakshman

The Va Medical Center and Georgetown University and the George Washington University Washington D.C. USA

Several studies indicate that blockade of the renin-angiotensin-aldosterone system (RAAS) can prevent atherosclerosis and vascular events, but the precise mechanisms involved are still unclear. In this study, we investigated the effect of the AT ₁-receptor blocker, candesartan, in the prevention of atherosclerosis in Watanabe heritable hyperlipidaemic (WHHL) rabbits and also the effect of AT₁-receptor blockade in the uptake of oxidised LDL by macrophage cell cultures. In the first set of experiments, 12 WHHL rabbits were randomly assigned to three groups: placebo, atenolol 5 mg/kg daily or candesartan 2 mg/kg daily for six months. Compared with controls and atenolol-treated rabbits, candesartan treatment resulted in a significant 50—60% reduction of atherosclerotic plaque formation and a 66% reduction in cholesterol accumulation in the thoracic aorta.

Studies in macrophage cultures indicated that candesartan prevented uptake of oxidised LDL-(oxLDL)-cholesterol by cultured macrophages. Candesartan inhibited the uptake of oxLDL in a dose-dependent manner, reaching a maximum inhibition of 70% at concentrations of 5.6 µg/ml. Further studies in other animal models and well-designed trials in humans are warranted to further explore the role of AT₁-receptor blockade in the prevention of atherosclerosis.

Key Words: telmisartan • lisinopril • antihypertensive • hypertension • diabetes • renoprotection • angiotensin II receptor antagonist

References

• Aldeman MH, Madhaven S., Ooi WL, Cohen H., Sealy JE, Laragh JH Association of the renin-sodium profile with the risk ofmyocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-104.[Abstract]
• Gombien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rutherford JD, Pfeffer MA, Moye LA et al. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement Trial: SAVE Investigators, Circulation 1994;90:1731-8.[Abstract/Free Full Text]
• Yusuf S., Pepine CJ, Garces C. et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• The Heart Outcomes Prevention Evaluation Study (HOPE) Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-3.[Abstract/Free Full Text]
• Ferrario CM, Deitch JS, Dean RH, Strawn WB Hypertension and atherosclerosis: a mechanistic understanding of disease progression. Cardiovasc Risk Factors 1996;6:299-310.
• Clozel M., Kuhn H., Hefti F., Baumgartner HR Endothelial dysfunction and subendothelial monocyte macrophages in hypertension.Hypertension 1991;18:132-41.[Abstract/Free Full Text]
• Yanagitani Y., Rakugi A., Okamura A. et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 1999;33(pt II):II-335-9.
• Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM Angiotensin II induces monocyte chemoattractant protein-1 gene expresson in rat vascular smooth muscle cells. Circ Res 1998;83:952-9.[Abstract/Free Full Text]
• Tummala PE, Chen XL, Sundell CL et al. Ang II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999;100:1223-9.[Abstract/Free Full Text]
• Rajagopalan S., Kurz S., Munzel T. et al. Ang II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.[Web of Science][Medline] [Order article via Infotrieve]
• Chobanian AV, Haudenschild CC, Nickerson C., Drago R. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;1:327-31.
• Chobanian AV, Haudenschild CC, Nickerson C., Hope S. Trandolapril inhibits atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit. Hypertension 1992;20:473-7.[Abstract/Free Full Text]
• Schuh JR, Blehmn DJ, Friedrich GE et al. Differential effects of renin-angiotensin blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993;91:1453-8.[Web of Science][Medline] [Order article via Infotrieve]
• Charpiot P., Rolland P.h, Friggi A. et al. ACE-I with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arterioscler Thromb 1993;13:1125-38.[Abstract/Free Full Text]
• Kowala MC, Grove RI,Aberg G. Inhibitors of angiotensin-converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophase-foam cell accumulation independently of BP and plasma lipids. Atherosclerosis 1994;108:61-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chobanian AV, Hope S., Brecher P. Dissociation between antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe Heritable Hyperlipidemic rabbit. Hypertension 1995;25:1306-10.[Abstract/Free Full Text]
• Sugano M., Makino N., Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.Atherosclerosis 1996;127:123-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hope S., Brecher P., Chobanian AV Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.AmJHypertens 1999;12:28-34.[Web of Science][Medline] [Order article via Infotrieve]
• Allain CA, Poon LS, Chan CSG, Richmond W., Fu PC Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-3.[Abstract]
• Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Nat Acad Sci 1981;78:7545-9.[Abstract/Free Full Text]
• Esterbauer H., Striegl G., Puhl H., Rothhender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 1989;6:67-75.[Web of Science][Medline] [Order article via Infotrieve]
• Van Niekerk JLM, Hendriks T., Deboer HHM, Van't Laar A. Does nifedipine suppress atherogenesis in WHHL rabbits: Atherosclerosis 1984:53:91-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tilton GD, Buja LM, Bilheimer DW et al. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanbe heritable hyperlipidemic rabbit: an animal model of familial hypercholsterolemia. J Am Coll Cardiol 1985;6:141-4.[Abstract]
• Lichtenstein AH, Drago R., Nickerson C. et al.The effect of propranolol on atherogenesis in the Watanabe heritable hyperlipidemic rabbit.JVasc Med Biol 1989;1:248-54.
• Strawn WB, Chappell MC, Dean RH, Kivlighn S., Ferrario CM Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolaemia. Circulation 2000;101:1586-93.[Abstract/Free Full Text]
• Stary HC, Chandler AB, Glagov S. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. American Heart Association. Arterioscler Thromb 1994;14:840-56.[Abstract/Free Full Text]
• Li DY, Zhang YC, Philips MI, Sawamura T., Mehta JL Upregulation of endothelial receptor for oxidised low-density liproprotein (LOX-1) in cultured human coronary artery endothelial cells by Ang II type 1 receptor activation. Cir Res 1999;84:1043-49.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl, S77-S80 (2001)
DOI: 10.1177/14703203010020011301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Papademetriou, V. Articles by Lakshman, R. Search for Related Content PubMed Articles by Papademetriou, V. Articles by Lakshman, R. Social Bookmarking                         What's this?